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7Obesity Paradox” or a Better Nutritional
tatus?
o the Editor:
We read with great interest the recent article by Uretsky
t al1 about obesity’s impact on survival in patients with
ardiovascular disease. However, some aspects of the study
re worthy of comment.
First, the study has serious limitations, such as the short-
erm follow-up and the younger age of obese patients com-
ared with normal-weight patients. We suggest that the
onsequences of obesity on mortality could be delayed and
ot observed in short-term studies. When long-term out-
ome is evaluated, it should take into account all classical
isk factors related to obesity. Eilat-Adar et al2 reported a
urposeful weight reduction in obese patients with cardio-
ascular disease, with a lower long-term incidence of car-
iovascular events, despite the “obesity paradox.”
Second, the authors discussed the cardioprotective role
f soluble TNF “antagonist” receptors produced by adi-
ose tissue.3 However, if adipose tissue releases these in-
ibitors, it also produces pro-inflammatory cytokines and in-
ammatory mediators, as recently observed by our group.4
n addition, intentional weight loss reduced the production of
ro-inflammatory cytokines by adipose tissue and increased
he expression of anti-inflammatory cytokines (ie, IL-10).5
Third, body mass index (BMI) is not a direct measure of
ody composition and does not reflect the body muscle
ass content, reduced in patients with chronic diseases.6
ubjects with a well-represented muscle mass show a lower
ardiovascular mortality.7
In conclusion, we suggest that an association between
igher BMI and better survival in patients with cardiovas-
ular disease should be re-evaluated in concert with nutri-
ional status assessment. Higher BMI may confer a survival
dvantage if muscle mass is well represented. We recom-
002-9343/$ -see front matter © 2008 Elsevier Inc. All rights reserved.end easy and noninvasive body composition methods
such as bioelectrical impedance analysis) to more accu-
ately evaluate the relationship between BMI and mortality.
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